Tilray Brands announced on Monday a new scientific publication supported by Tilray Medical. The study examines the real-world impact of cannabinoid treatments on patients with fibromyalgia. The study ...

Patients with fibromyalgia who used cannabis-based medicinal products demonstrated modest, medium-term improvements in pain, anxiety and sleep, according to data published in Clinical Rheumatology.“It ...

InMed Pharmaceuticals is making strides in Alzheimer’s research with its development of a cannabinoid-based compound that aims to protect and rejuvenate brain neurons. During Benzinga’s virtual event ...

BOSTON--(BUSINESS WIRE)--EO Care, a leader in clinically guided cannabinoid-based healthcare treatment, announced today that Milliman, a premier global consulting and actuarial firm, completed its ...

A cannabinoid our bodies produce naturally has been found, in a new study, to play a role in the inappropriate regulation of fear responses characteristic of conditions like anxiety and PTSD. The ...

Hawai‘i’s medical cannabis program is effectively serving patient needs and is a the primary source of cannabis for the ...

Users of Medicinal Cannabis will also be asked if they can participate in follow-up phone interviews. Researchers will make ...

How can cannabis be used to help chemotherapy patients? This is what a recent study published in Pharmacology & Therapeutics hopes to address as a team of researchers investigated how cannabinoids ...

Dr. Raphael Mechoulam, widely regarded as the “Father of Cannabinoid Research,” is a pioneering scientist whose groundbreaking work in the 1960s transformed our understanding of cannabis. Through his ...

A Kentucky medical cannabis practitioner says the expansion could offer alternatives to opioids for roughly 430,000 people.

The study showed that the medical cannabis system gets up to 87% of all spending by registered patients.

The next big thing for cannabis in Massachusetts isn’t just expansion. It’s alignment. It’s honesty. It’s growing up without losing sight of why we started.